It explains where the 2 Technology Appraisals for sodium-glucose co-transporter-2 inhibitors (SGLT2 inhibitors) published by the National Institute for Health and Care ... diagnosis and management ...
BioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea ...